Changes to MBS items 30196 and 30202

Page last updated: 03 March 2021

From 1 March 2021, a change to MBS items for the removal of malignant neoplasm of skin or mucous membrane by serial curettage, carbon dioxide laser or erbium laser excision-ablation (item 30196) and by liquid nitrogen cryotherapy (item 30202) will allow specialists in the specialty of plastic surgery to claim the item when using their clinical expertise to confirm a neoplasm to be malignant, provided a specimen has been submitted for histological confirmation.

These changes follow consultation with dermatology, plastic surgery and skin services providers who advised that it was appropriate that both dermatologists and plastic surgeons be allowed to claim the item when using their clinical expertise to confirm a neoplasm to be malignant, provided a specimen has been submitted for histological confirmation.

Further information about the changes to items 30196 and 30202 is detailed in the below factsheet.

Factsheet items 30196 and 30202( PDF (261 KB)

Factsheet items 30196 and 30202( DOCX (92 KB)

In this section